메뉴 건너뛰기




Volumn 72, Issue 12, 2008, Pages 1937-1945

Better survival with statin administration after revascularization therapy in Japanese patients with coronary artery disease - Perspectives from the CREDO-Kyoto Registry

(95)  Furukawa, Yutaka a,c   Taniguchi, Ryoji b   Ehara, Natsuhiko a   Ozasa, Neiko c   Haruna, Yoshisumi d   Saito, Naritatsu c   Doi, Takahiro c   Hoshino, Kozo e   Shizuta, Satoshi c   Morimoto, Takeshi f   Imai, Yukiko g   Teramukai, Satoshi g,t   Fukushima, Masanori g,t   Kita, Toru c   Kimura, Takeshi c   Lee, Jong Dae h   Tanaka, Kuniyoshi h   Okazaki, Katsuo i   Takahashi, Masaaki j   Oda, Teiji j   more..


Author keywords

Coronary artery disease; Mortality; Revascularization; Statins

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT RECEPTOR; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; NITRATE; TICLOPIDINE;

EID: 56849126602     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-08-0293     Document Type: Article
Times cited : (26)

References (36)
  • 1
    • 0034158058 scopus 로고    scopus 로고
    • Modern adjunctive pharmacotherapy of myocardial infarction
    • Prasad A, Reeder G. Modern adjunctive pharmacotherapy of myocardial infarction. Expert Opin Pharmacother 2000; 1: 405-418.
    • (2000) Expert Opin Pharmacother , vol.1 , pp. 405-418
    • Prasad, A.1    Reeder, G.2
  • 3
    • 0027987849 scopus 로고
    • Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study (4S)
    • Group SSSS
    • Group SSSS. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study (4S). Lancet 1994; 344: 1383-1389.
    • (1994) Lancet , vol.344 , pp. 1383-1389
  • 4
    • 0028883828 scopus 로고
    • Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia: West of Scotland Coronary Prevention Study Group
    • Shepherd J, Cobbe SM, Ford I, Isles CG, Lorimer AR, MacFarlane PW, et al. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia: West of Scotland Coronary Prevention Study Group. N Engl J Med 1995; 333: 1301-1307.
    • (1995) N Engl J Med , vol.333 , pp. 1301-1307
    • Shepherd, J.1    Cobbe, S.M.2    Ford, I.3    Isles, C.G.4    Lorimer, A.R.5    MacFarlane, P.W.6
  • 5
    • 0342981862 scopus 로고    scopus 로고
    • The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels: Cholesterol and Recurrent Events Trial investigators
    • Sacks FM, Pfeffer MA, Moye LA, Rouleau JL, Rutherford JD, Cole TG, et al. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels: Cholesterol and Recurrent Events Trial investigators. N Engl J Med 1996; 335: 1001-1009.
    • (1996) N Engl J Med , vol.335 , pp. 1001-1009
    • Sacks, F.M.1    Pfeffer, M.A.2    Moye, L.A.3    Rouleau, J.L.4    Rutherford, J.D.5    Cole, T.G.6
  • 6
    • 0031030620 scopus 로고    scopus 로고
    • The effect of aggressive lowering of low-density lipoprotein cholesterol levels and low-dose anticoagulation on obstructive changes in saphenous-vein coronary-artery bypass grafts: The Post Coronary Artery Bypass Graft Trial Investigators
    • Investigators TPCABGT
    • Investigators TPCABGT. The effect of aggressive lowering of low-density lipoprotein cholesterol levels and low-dose anticoagulation on obstructive changes in saphenous-vein coronary-artery bypass grafts: The Post Coronary Artery Bypass Graft Trial Investigators. N Engl J Med 1997; 336: 153-162.
    • (1997) N Engl J Med , vol.336 , pp. 153-162
  • 7
    • 0032487931 scopus 로고    scopus 로고
    • Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels: The Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Group
    • Group TL-TIwPiIDLS
    • Group TL-TIwPiIDLS. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels: The Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Group. N Engl J Med 1998; 339: 1349-1357.
    • (1998) N Engl J Med , vol.339 , pp. 1349-1357
  • 8
    • 0033165564 scopus 로고    scopus 로고
    • Pravastatin prevents clinical events in revascularized patients with average cholesterol concentrations: Cholesterol and Recurrent Events (CARE) Investigators
    • Flaker GC, Warnica JW, Sacks FM, Moye LA, Davis BR, Rouleau JL, et al. Pravastatin prevents clinical events in revascularized patients with average cholesterol concentrations: Cholesterol and Recurrent Events (CARE) Investigators. J Am Coll Cardiol 1999; 34: 106-112.
    • (1999) J Am Coll Cardiol , vol.34 , pp. 106-112
    • Flaker, G.C.1    Warnica, J.W.2    Sacks, F.M.3    Moye, L.A.4    Davis, B.R.5    Rouleau, J.L.6
  • 9
    • 4344683381 scopus 로고    scopus 로고
    • Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): Multicentre randomised placebo-controlled trial
    • Colhoun HM, Betteridge DJ, Durrington PN, Hitman GA, Neil HA, Livingstone SJ, et al. Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): Multicentre randomised placebo-controlled trial. Lancet 2004; 364: 685-696.
    • (2004) Lancet , vol.364 , pp. 685-696
    • Colhoun, H.M.1    Betteridge, D.J.2    Durrington, P.N.3    Hitman, G.A.4    Neil, H.A.5    Livingstone, S.J.6
  • 10
    • 3342996744 scopus 로고    scopus 로고
    • Effect of atorvastatin on risk of recurrent cardiovascular events after an acute coronary syndrome associated with high soluble CD40 ligand in the Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (MIRACL) Study
    • Kinlay S, Schwartz GG, Olsson AG, Rifai N, Sasiela WJ, Szarek M, et al. Effect of atorvastatin on risk of recurrent cardiovascular events after an acute coronary syndrome associated with high soluble CD40 ligand in the Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (MIRACL) Study. Circulation 2004; 110: 386-391.
    • (2004) Circulation , vol.110 , pp. 386-391
    • Kinlay, S.1    Schwartz, G.G.2    Olsson, A.G.3    Rifai, N.4    Sasiela, W.J.5    Szarek, M.6
  • 11
  • 12
    • 0037178569 scopus 로고    scopus 로고
    • Fluvastatin for prevention of cardiac events following successful first percutaneous coronary intervention: A randomized controlled trial
    • Serruys PW, de Feyter P, Macaya C, Kokott N, Puel J, Vrolix M, et al. Fluvastatin for prevention of cardiac events following successful first percutaneous coronary intervention: A randomized controlled trial. JAMA 2002; 287: 3215-3222.
    • (2002) JAMA , vol.287 , pp. 3215-3222
    • Serruys, P.W.1    de Feyter, P.2    Macaya, C.3    Kokott, N.4    Puel, J.5    Vrolix, M.6
  • 13
    • 33645235635 scopus 로고    scopus 로고
    • Cardioprotective strategies to improve long-term outcomes following coronary artery bypass surgery
    • Arora R, Sowers JR, Saunders E, Probstfield J, Lazar HL. Cardioprotective strategies to improve long-term outcomes following coronary artery bypass surgery. J Card Surg 2006; 21: 198-204.
    • (2006) J Card Surg , vol.21 , pp. 198-204
    • Arora, R.1    Sowers, J.R.2    Saunders, E.3    Probstfield, J.4    Lazar, H.L.5
  • 14
    • 33748303084 scopus 로고    scopus 로고
    • Reduction of low-density lipoprotein cholesterol in patients with coronary heart disease and metabolic syndrome: Analysis of the Treating to New Targets study
    • Deedwania P, Barter P, Carmena R, Fruchart JC, Grundy SM, Haffner S, et al. Reduction of low-density lipoprotein cholesterol in patients with coronary heart disease and metabolic syndrome: Analysis of the Treating to New Targets study. Lancet 2006; 368: 919-928.
    • (2006) Lancet , vol.368 , pp. 919-928
    • Deedwania, P.1    Barter, P.2    Carmena, R.3    Fruchart, J.C.4    Grundy, S.M.5    Haffner, S.6
  • 15
    • 33748952489 scopus 로고    scopus 로고
    • Primary prevention of cardiovascular disease with pravastatin in Japan (MEGA Study): A prospective randomised controlled trial
    • Nakamura H, Arakawa K, Itakura H, Kitabatake A, Goto Y, Toyota T, et al. Primary prevention of cardiovascular disease with pravastatin in Japan (MEGA Study): A prospective randomised controlled trial. Lancet 2006; 368: 1155-1163.
    • (2006) Lancet , vol.368 , pp. 1155-1163
    • Nakamura, H.1    Arakawa, K.2    Itakura, H.3    Kitabatake, A.4    Goto, Y.5    Toyota, T.6
  • 16
    • 33645737679 scopus 로고    scopus 로고
    • Effects of early statin treatment on symptomatic heart failure and ischemic events after acute myocardial infarction in Japanese
    • Sakamoto T, Kojima S, Ogawa H, Shimomura H, Kimura K, Ogata Y, et al. Effects of early statin treatment on symptomatic heart failure and ischemic events after acute myocardial infarction in Japanese. Am J Cardiol 2006; 97: 1165-1171.
    • (2006) Am J Cardiol , vol.97 , pp. 1165-1171
    • Sakamoto, T.1    Kojima, S.2    Ogawa, H.3    Shimomura, H.4    Kimura, K.5    Ogata, Y.6
  • 17
    • 39849090518 scopus 로고    scopus 로고
    • Effect of early use of low-dose pravastatin on major adverse cardiac events in patients with acute myocardial infarction: The OACIS-LIPID Study
    • Sato H, Kinjo K, Ito H, Hirayama A, Nanto S, Fukunami M, et al. Effect of early use of low-dose pravastatin on major adverse cardiac events in patients with acute myocardial infarction: The OACIS-LIPID Study. Circ J 2008; 72: 17-22.
    • (2008) Circ J , vol.72 , pp. 17-22
    • Sato, H.1    Kinjo, K.2    Ito, H.3    Hirayama, A.4    Nanto, S.5    Fukunami, M.6
  • 18
    • 34248683634 scopus 로고    scopus 로고
    • Effect of early statin treatment at standard doses on long-term clinical outcomes in patients with acute myocardial infarction (the Heart Institute of Japan, Department of Cardiology Statin Evaluation Program)
    • Nagashima M, Koyanagi R, Kasanuki H, Hagiwara N, Yamaguchi J, Atsuchi N, et al. Effect of early statin treatment at standard doses on long-term clinical outcomes in patients with acute myocardial infarction (the Heart Institute of Japan, Department of Cardiology Statin Evaluation Program). Am J Cardiol 2007; 99: 1523-1528.
    • (2007) Am J Cardiol , vol.99 , pp. 1523-1528
    • Nagashima, M.1    Koyanagi, R.2    Kasanuki, H.3    Hagiwara, N.4    Yamaguchi, J.5    Atsuchi, N.6
  • 19
    • 37149041747 scopus 로고    scopus 로고
    • Effects of medication on cardiovascular events in the Japanese coronary artery disease (JCAD) study
    • Kohro T, Hayashi D, Okada Y, Yamazaki T, Nagai R. Effects of medication on cardiovascular events in the Japanese coronary artery disease (JCAD) study. Circ J 2007; 71: 1835-1840.
    • (2007) Circ J , vol.71 , pp. 1835-1840
    • Kohro, T.1    Hayashi, D.2    Okada, Y.3    Yamazaki, T.4    Nagai, R.5
  • 20
    • 54449097477 scopus 로고    scopus 로고
    • Long-term outcomes of coronary-artery bypass graft surgery versus percutaneous coronary intervention for multivessel coronary artery disease in the bare-metal stent era
    • Kimura T, Morimoto T, Furukawa Y, Nakagawa Y, Shizuta S, Ehara N, et al. Long-term outcomes of coronary-artery bypass graft surgery versus percutaneous coronary intervention for multivessel coronary artery disease in the bare-metal stent era. Circulation 2008; 118(Suppl): S199-S209.
    • (2008) Circulation , vol.118 , Issue.SUPPL.
    • Kimura, T.1    Morimoto, T.2    Furukawa, Y.3    Nakagawa, Y.4    Shizuta, S.5    Ehara, N.6
  • 21
    • 23644462088 scopus 로고    scopus 로고
    • Five-year outcomes after coronary stenting versus bypass surgery for the treatment of multivessel disease: The final analysis of the Arterial Revascularization Therapies Study (ARTS) randomized trial
    • Serruys PW, Ong AT, van Herwerden LA, Sousa JE, Jatene A, Bonnier JJ, et al. Five-year outcomes after coronary stenting versus bypass surgery for the treatment of multivessel disease: The final analysis of the Arterial Revascularization Therapies Study (ARTS) randomized trial. J Am Coll Cardiol 2005; 46: 575-581.
    • (2005) J Am Coll Cardiol , vol.46 , pp. 575-581
    • Serruys, P.W.1    Ong, A.T.2    van Herwerden, L.A.3    Sousa, J.E.4    Jatene, A.5    Bonnier, J.J.6
  • 22
    • 0030862072 scopus 로고    scopus 로고
    • Estimating causal effects from large data sets using propensity scores
    • Rubin DB. Estimating causal effects from large data sets using propensity scores. Ann Intern Med 1997; 127: 757-763.
    • (1997) Ann Intern Med , vol.127 , pp. 757-763
    • Rubin, D.B.1
  • 23
    • 3543135271 scopus 로고    scopus 로고
    • Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group
    • D'Agostino RB Jr. Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group. Stat Med 1998; 17: 2265-2281.
    • (1998) Stat Med , vol.17 , pp. 2265-2281
    • D'Agostino Jr., R.B.1
  • 24
    • 2542472461 scopus 로고    scopus 로고
    • Propensity analysis of long-term survival after surgical or percutaneous revascularization in patients with multivessel coronary artery disease and high-risk features
    • Brener SJ, Lytle BW, Casserly IP, Schneider JP, Topol EJ, Lauer MS. Propensity analysis of long-term survival after surgical or percutaneous revascularization in patients with multivessel coronary artery disease and high-risk features. Circulation 2004; 109: 2290-2295.
    • (2004) Circulation , vol.109 , pp. 2290-2295
    • Brener, S.J.1    Lytle, B.W.2    Casserly, I.P.3    Schneider, J.P.4    Topol, E.J.5    Lauer, M.S.6
  • 25
    • 0034761453 scopus 로고    scopus 로고
    • Coronary heart disease mortality among men aged 35-44 years by prefecture in Japan in 1995-1999 compared with that among white men aged 35-44 by state in the United States in 1995-1998: Vital statistics data in recent birth cohort
    • Sekikawa A, Satoh T, Hayakawa T, Ueshima H, Kuller LH. Coronary heart disease mortality among men aged 35-44 years by prefecture in Japan in 1995-1999 compared with that among white men aged 35-44 by state in the United States in 1995-1998: Vital statistics data in recent birth cohort. Jpn Circ J 2001; 65: 887-892.
    • (2001) Jpn Circ J , vol.65 , pp. 887-892
    • Sekikawa, A.1    Satoh, T.2    Hayakawa, T.3    Ueshima, H.4    Kuller, L.H.5
  • 26
    • 33847343501 scopus 로고    scopus 로고
    • Less subclinical atherosclerosis in Japanese men in Japan than in White men in the United States in the post-World War II birth cohort
    • Sekikawa A, Ueshima H, Kadowaki T, El-Saed A, Okamura T, Takamiya T, et al. Less subclinical atherosclerosis in Japanese men in Japan than in White men in the United States in the post-World War II birth cohort. Am J Epidemiol 2007; 165: 617-624.
    • (2007) Am J Epidemiol , vol.165 , pp. 617-624
    • Sekikawa, A.1    Ueshima, H.2    Kadowaki, T.3    El-Saed, A.4    Okamura, T.5    Takamiya, T.6
  • 28
    • 20644463210 scopus 로고    scopus 로고
    • Patients undergoing coronary revascularisation: A missed opportunity for secondary prevention?
    • Fox DJ, Kibiro M, Eichhofer J, Curzen NP. Patients undergoing coronary revascularisation: A missed opportunity for secondary prevention? Postgrad Med J 2005; 81: 401-403.
    • (2005) Postgrad Med J , vol.81 , pp. 401-403
    • Fox, D.J.1    Kibiro, M.2    Eichhofer, J.3    Curzen, N.P.4
  • 29
    • 4043133008 scopus 로고    scopus 로고
    • Randomized trial of atorvastatin for reduction of myocardial damage during coronary intervention: Results from the ARMYDA (Atorvastatin for Reduction of MYocardial Damage during Angioplasty) study
    • Pasceri V, Patti G, Nusca A, Pristipino C, Richichi G, Di Sciascio G. Randomized trial of atorvastatin for reduction of myocardial damage during coronary intervention: Results from the ARMYDA (Atorvastatin for Reduction of MYocardial Damage during Angioplasty) study. Circulation 2004; 110: 674-678.
    • (2004) Circulation , vol.110 , pp. 674-678
    • Pasceri, V.1    Patti, G.2    Nusca, A.3    Pristipino, C.4    Richichi, G.5    Di Sciascio, G.6
  • 30
    • 34547596559 scopus 로고    scopus 로고
    • Randomized trial of statin administration for myocardial injury: Is intensive lipid-lowering more beneficial than moderate lipid-lowering before percutaneous coronary intervention?
    • Kinoshita M, Matsumura S, Sueyoshi K, Ogawa S, Fukuda K. Randomized trial of statin administration for myocardial injury: Is intensive lipid-lowering more beneficial than moderate lipid-lowering before percutaneous coronary intervention? Circ J 2007; 71: 1225-1228.
    • (2007) Circ J , vol.71 , pp. 1225-1228
    • Kinoshita, M.1    Matsumura, S.2    Sueyoshi, K.3    Ogawa, S.4    Fukuda, K.5
  • 31
    • 4644324135 scopus 로고    scopus 로고
    • Statins are associated with a reduced incidence of perioperative mortality after coronary artery bypass graft surgery
    • II-45-II-49
    • Pan W, Pintar T, Anton J, Lee VV, Vaughn WK, Collard CD. Statins are associated with a reduced incidence of perioperative mortality after coronary artery bypass graft surgery. Circulation 2004; 110(Suppl): II-45-II-49.
    • (2004) Circulation , vol.110 , Issue.SUPPL.
    • Pan, W.1    Pintar, T.2    Anton, J.3    Lee, V.V.4    Vaughn, W.K.5    Collard, C.D.6
  • 32
    • 23944497531 scopus 로고    scopus 로고
    • Effect of statin use within the first 24 hours of admission for acute myocardial infarction on early morbidity and mortality
    • Fonarow GC, Wright RS, Spencer FA, Fredrick PD, Dong W, Every N, et al. Effect of statin use within the first 24 hours of admission for acute myocardial infarction on early morbidity and mortality. Am J Cardiol 2005; 96: 611-616.
    • (2005) Am J Cardiol , vol.96 , pp. 611-616
    • Fonarow, G.C.1    Wright, R.S.2    Spencer, F.A.3    Fredrick, P.D.4    Dong, W.5    Every, N.6
  • 33
    • 33749460868 scopus 로고    scopus 로고
    • Statin use is independently associated with smaller infarct volume in nonlacunar MCA territory stroke
    • Shook SJ, Gupta R, Vora NA, Tievsky AL, Katzan I, Krieger DW. Statin use is independently associated with smaller infarct volume in nonlacunar MCA territory stroke. J Neuroimaging 2006; 16: 341-346.
    • (2006) J Neuroimaging , vol.16 , pp. 341-346
    • Shook, S.J.1    Gupta, R.2    Vora, N.A.3    Tievsky, A.L.4    Katzan, I.5    Krieger, D.W.6
  • 34
    • 33947523389 scopus 로고    scopus 로고
    • Prior statin use may be associated with improved stroke outcome after tissue plasminogen activator
    • Alvarez-Sabin J, Huertas R, Quintana M, Rubiera M, Delgado P, Ribo M, et al. Prior statin use may be associated with improved stroke outcome after tissue plasminogen activator. Stroke 2007; 38: 1076-1078.
    • (2007) Stroke , vol.38 , pp. 1076-1078
    • Alvarez-Sabin, J.1    Huertas, R.2    Quintana, M.3    Rubiera, M.4    Delgado, P.5    Ribo, M.6
  • 35
    • 21044441796 scopus 로고    scopus 로고
    • The initial management of stable angina in Europe, from the Euro Heart Survey: A description of pharmacological management and revascularization strategies initiated within the first month of presentation to a cardiologist in the Euro Heart Survey of Stable Angina
    • Daly CA, Clemens F, Sendon JL, Tavazzi L, Boersma E, Danchin N, et al. The initial management of stable angina in Europe, from the Euro Heart Survey: A description of pharmacological management and revascularization strategies initiated within the first month of presentation to a cardiologist in the Euro Heart Survey of Stable Angina. Eur Heart J 2005; 26: 1011-1022.
    • (2005) Eur Heart J , vol.26 , pp. 1011-1022
    • Daly, C.A.1    Clemens, F.2    Sendon, J.L.3    Tavazzi, L.4    Boersma, E.5    Danchin, N.6
  • 36
    • 0034646207 scopus 로고    scopus 로고
    • Major racial differences in coronary constrictor response between Japanese and Caucasians with recent myocardial infarction
    • Pristipino C, Beltrame JF, Finocchiaro ML, Hattori R, Fujita M, Mongiardo R, et al. Major racial differences in coronary constrictor response between Japanese and Caucasians with recent myocardial infarction. Circulation 2000; 101: 1102-1108.
    • (2000) Circulation , vol.101 , pp. 1102-1108
    • Pristipino, C.1    Beltrame, J.F.2    Finocchiaro, M.L.3    Hattori, R.4    Fujita, M.5    Mongiardo, R.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.